+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07294638

Study of a Humanized Ferritin-Based Near-Infrared Fluorescent Probe to Detect Cancer Spread in Lymph Nodes for Early Gastric Cancer

Led by Nanfang Hospital, Southern Medical University · Updated on 2025-12-19

47

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Early gastric cancer EGC is increasingly detected due to widespread early screening, with treatments mainly involving endoscopic or surgical methods. For cases where EGC invades the submucosal layer, about 20% show lymph node metastasis, yet many patients undergo unnecessary lymph node removal. Sentinel lymph nodes SLNs are the first sites likely to harbor metastases and can indicate lymphatic spread. This study evaluates a new humanized ferritin-based near-infrared NIR fluorescent probe, VECX-FTn-ICG, designed to better identify metastatic SLNs and distinguish between benign and malignant nodes during surgery, aiming to reduce unnecessary lymphadenectomy and improve outcomes in early gastric cancer patients. The study involves injecting the VECX-FTn-ICG probe into freshly removed gastric cancer tissue samples ex vivo. After about 60 minutes, fluorescence imaging is performed to detect metastatic lymph nodes among the SLNs. This probe targets tumor cells with high specificity and uses molecular imaging technology combined with NIR fluorescence to provide accurate real-time imaging. The study will assess the probes diagnostic accuracy, including its ability to identify SLN metastasis of various sizes, by analyzing the imaging results from early gastric cancer surgical specimens. Participants provide consent for use of their surgical tissue samples to test the probes imaging capabilities. The primary outcome measured is the area under the curve AUC to evaluate how well the probe diagnoses SLN metastasis within one year. This research aims to offer a reliable tool for intraoperative SLN biopsy in early gastric cancer, potentially helping surgeons avoid unnecessary lymph node removal and improving patient prognosis through more precise detection.

CONDITIONS

Brief Title

Novel Humanized Ferritin-Based NIR Fluorescent Probe for Identifying Sentinel Lymph Node Metastasis in Early Gastric Cancer

Research Team

Y

Yanfeng Hu

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here